These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20237938)

  • 41. Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer.
    Cano CE; Sandí MJ; Hamidi T; Calvo EL; Turrini O; Bartholin L; Loncle C; Secq V; Garcia S; Lomberk G; Kroemer G; Urrutia R; Iovanna JL
    EMBO Mol Med; 2012 Sep; 4(9):964-79. PubMed ID: 22821859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent insights into the biology of pancreatic cancer.
    Yao W; Maitra A; Ying H
    EBioMedicine; 2020 Mar; 53():102655. PubMed ID: 32139179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biology of metastases and molecular mechanisms of their formation].
    Coussy F; Bonin F; Azorin P; Tariq Z; Driouch K
    Bull Cancer; 2019 Jan; 106(1):24-36. PubMed ID: 30554635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Forecasting sensitive targets of the kynurenine pathway in pancreatic adenocarcinoma using mathematical modeling.
    Alahdal M; Sun D; Duan L; Ouyang H; Wang M; Xiong J; Wang D
    Cancer Sci; 2021 Apr; 112(4):1481-1494. PubMed ID: 33523522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental animal models of pancreatic carcinogenesis and metastasis.
    Wei D; Xiong HQ; Abbruzzese JL; Xie K
    Int J Gastrointest Cancer; 2003; 33(1):43-60. PubMed ID: 12909737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential.
    Pedersen SF; Stock C
    Cancer Res; 2013 Mar; 73(6):1658-61. PubMed ID: 23302229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell and molecular biology of pancreatic carcinoma. Proceedings of the Baltic Pancreas Meeting on Pancreatic Carcinoma from Bench to Bedside. Rostock-Warnemunde, Germany, September 17-18, 1998.
    Ann N Y Acad Sci; 1999 Jun; 880():1-380. PubMed ID: 10454966
    [No Abstract]   [Full Text] [Related]  

  • 48. Instantaneous mutation rate in cancer initiation and progression.
    Sun S; Klebaner F; Zhang X; Tian T
    BMC Syst Biol; 2018 Nov; 12(Suppl 6):110. PubMed ID: 30463617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pancreatic cancer from bench to bedside: molecular pathways and treatment options.
    Kosmidis C; Sapalidis K; Kotidis E; Mixalopoulos N; Zarogoulidis P; Tsavlis D; Baka S; Man YG; Kanellos J
    Ann Transl Med; 2016 May; 4(9):165. PubMed ID: 27275478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer metastasis as disrupted developmental phenotype.
    Ishii H; Saito T
    Curr Genomics; 2008 Mar; 9(1):25-8. PubMed ID: 19424481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The molecular biology of brain metastasis.
    Rahmathulla G; Toms SA; Weil RJ
    J Oncol; 2012; 2012():723541. PubMed ID: 22481931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in understanding the molecular mechanism of pancreatic cancer metastasis.
    Du YX; Liu ZW; You L; Wu WM; Zhao YP
    Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):361-70. PubMed ID: 27498575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.
    Morris JP; Wang SC; Hebrok M
    Nat Rev Cancer; 2010 Oct; 10(10):683-95. PubMed ID: 20814421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EMT and dissemination precede pancreatic tumor formation.
    Rhim AD; Mirek ET; Aiello NM; Maitra A; Bailey JM; McAllister F; Reichert M; Beatty GL; Rustgi AK; Vonderheide RH; Leach SD; Stanger BZ
    Cell; 2012 Jan; 148(1-2):349-61. PubMed ID: 22265420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study.
    Turner MA; Cox KE; Neel N; Amirfakhri S; Nishino H; Clary BM; Hosseini M; Natarajan G; Mallya K; Mohs AM; Hoffman RM; Batra SK; Bouvet M
    J Pers Med; 2023 May; 13(5):. PubMed ID: 37241027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of microbiota and microbiota-derived short-chain fatty acids in PDAC.
    Temel HY; Kaymak Ö; Kaplan S; Bahcivanci B; Gkoutos GV; Acharjee A
    Cancer Med; 2023 Mar; 12(5):5661-5675. PubMed ID: 36205023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laminarin Attenuates ROS-Mediated Cell Migration and Invasiveness through Mitochondrial Dysfunction in Pancreatic Cancer Cells.
    Lee W; Song G; Bae H
    Antioxidants (Basel); 2022 Aug; 11(9):. PubMed ID: 36139787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer.
    Knoche SM; Brumfield GL; Goetz BT; Sliker BH; Larson AC; Olson MT; Poelaert BJ; Bavari A; Yan Y; Black JD; Solheim JC
    PLoS One; 2022; 17(9):e0273518. PubMed ID: 36126055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome‑wide DNA hypomethylation drives a more invasive pancreatic cancer phenotype and has predictive occult distant metastasis and prognosis potential.
    Endo Y; Suzuki K; Kimura Y; Tamaki S; Aizawa H; Abe I; Watanabe F; Kato T; Saito M; Futsuhara K; Noda H; Konishi F; Rikiyama T
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35419613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways.
    Yang C; Zhang L; Huang H; Yuan X; Zhang P; Ye C; Wei M; Huang Y; Luo X; Luo J
    Genes Dis; 2022 Mar; 9(2):466-478. PubMed ID: 35224161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.